Transdermal nicotine: clarifications, side effects, and funding.
Ottervanger
J P
JP
Stricker
B H
BH
Klomps
H C
HC
D000279:Administration, Cutaneous; D001281:Atrial Fibrillation / Q000139:chemically induced; D005260:Female; D006801:Humans; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage* / Q000009:adverse effects; D016540:Smoking Cessation / Q000379:methods*
D009538:Nicotine